Tau Imaging with MK6240: A Possible Biomarker for Alzheimer’s Disease

The PI of this project was: Sterling Johnson, PhD

This project was funded by: NIH

The term of this project was: May 2017 to May 2018

The number of subjects scanned during this project was: 20

The overall goal of this study is to use the new tau tracer, MK6240, to determine tau burden (neurofibrillary tangles) in Alzheimer’s Disease (AD) vulnerable regions of the brain through PET scanning. This will be accomplished by employing imaging techniques (MRI and PET) and collecting biochemical biomarkers related to AD. Examining this pathology may provide an explanation for the very earliest cognitive changes that occur in AD.